Cancer Risk
Study register · detail Systematische Review · Cancer Risk · 2006

The association between Cannabis smoking and lung cancer: a systematic review.

Unclear GRADE High 171 citations
Samplek = 19 Studien
Duration1966 to October 2005
ControlTobacco smokers or non-smoking controls
EndpointLung cancer risk /…
Blindingn.a.
DesignSystematische Review
Cannabinoidvollspektrum
Routeinhalativ
Key finding

Evidence of premalignant lung changes due to cannabis smoking, but no confirmed association with lung cancer after tobacco adjustment.

Summary

Systematic review (k=19 studies, Archives of Internal Medicine) on cannabis smoking and lung cancer risk. Biological plausibility demonstrated: increased tar exposure, alveolar macrophage dysfunction, increased oxidative stress, bronchial histopathology vs. tobacco smokers and non-smokers. However, observational studies showed NO significant association between cannabis smoking and lung cancer incidence after adjustment for tobacco use. Methodological limitations (selection bias, small sample sizes, young participant age with insufficient latency period). Conclusion: definitive statements on cancer risk not possible; educating patients about potential risks recommended.

P
PopulationPersons aged 18 and older who smoke cannabis; primary studies on premalignant lung changes and lung cancer
I
InterventionCannabis smoking
C
ControlTobacco smokers or non-smoking controls
O
OutcomeNo significant association between cannabis smoking and lung cancer after adjustment for tobacco use; however, association with increased tar exposure, alveolar macrophage dysfunction, oxidative stress, and bronchial mucosal changes
Confidence in the evidence
High

The highest of four GRADE levels, the effect estimate is very reliable.

Quality profile
Sample size
Blinding
Effect size
Citations / year
Authors
Mehra R, Moore BA, Crothers K, Tetrault J, Fiellin DA.
DOI 10.1001/archinte.166.13.1359
Design: Systematische Review
Share
Abstract
<h4>Background</h4>The association between Cannabis smoking and lung cancer is unclear, and a systematic appraisal of this relationship has yet to be performed. Our objective was to assess the impact of Cannabis smoking on the development of premalignant lung changes and lung cancer.<h4>Methods</h4>Studies assessing the impact of Cannabis smoking on lung premalignant findings and lung cancer were selected from MEDLINE, PSYCHLIT, and EMBASE databases according to the following predefined criteria: English-language studies of persons 18 years or older identified from 1966 to the second week of October 2005 were included if they were research studies (ie, not letters, reviews, editorials, or limited case studies), involved persons who smoked Cannabis, and examined premalignant or cancerous changes in the lung.<h4>Results</h4>Nineteen studies met selection criteria. Studies that examined lung cancer risk factors or premalignant changes in the lung found an association of Cannabis smoking with increased tar exposure, alveolar macrophage tumoricidal dysfunction, increased oxidative stress, and bronchial mucosal histopathologic abnormalities compared with tobacco smokers or nonsmoking controls. Observational studies of subjects with Cannabis exposure failed to demonstrate significant associations between Cannabis smoking and lung cancer after adjusting for tobacco use. The primary methodologic deficiencies noted include selection bias, small sample size, limited generalizability, overall young participant age precluding sufficient lag time for lung cancer outcome identification, and lack of adjustment for tobacco smoking.<h4>Conclusion</h4>Given the prevalence of Cannabis smoking and studies predominantly supporting biological plausibility of an association of Cannabis smoking with lung cancer on the basis of molecular, cellular, and histopathologic findings, physicians should advise patients regarding potential adverse health outcomes until further rigorous studies are performed that permit definitive conclusions.

The impediment to action advances action. — Marcus Aurelius